Literature DB >> 7181475

Activity of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860) against picornaviruses in vitro.

R D Powers, J M Gwaltney, F G Hayden.   

Abstract

The newly synthesized compound 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860) has been found to inhibit picornavirus replication. In multiple growth cycle experiments, 1 microgram of MDL-860 per ml caused a reduction in virus yield of at least 1.0 log10 50% tissue culture infectious doses per 0.2 ml for 8 of 10 enteroviruses and 72 of 90 rhinovirus serotypes. This antiviral activity was dependent on both compound concentration and virus inoculum size. At concentrations that had no toxic effects on cell cultures, MDL-860 did not inhibit cytopathic effect or hemadsorption activity due to coronavirus 229-E, vesicular stomatitis virus, herpes simplex virus type 1, adenovirus, influenza virus A, or parainfluenza virus 1. Compound concentrations up to 25 micrograms/ml did not cause cytopathic effect in short-term cultures of rhesus monkey, WI-38, or HeLa cells; 10 micrograms/ml did not inhibit the replication of HeLa cells. The mechanism of action of MDL-860 has not been defined, although it was not directly virucidal and appeared to inhibit picornaviruses specifically at an early step in the virus-host cell interaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181475      PMCID: PMC183806          DOI: 10.1128/AAC.22.4.639

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Rhinovirus inhibition by 3-substituted triazinoindoles.

Authors:  J M Gwaltney
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

2.  Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).

Authors:  H L Torney; J K Dulworth; D L Steward
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

3.  Preliminary studies of the mode of action of arildone, a novel antiviral agent.

Authors:  M F Kuhrt; M J Fancher; V Jasty; F Pancic; P E Came
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

  3 in total
  12 in total

Review 1.  Chemotherapy of rhinovirus colds.

Authors:  S J Sperber; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

2.  Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).

Authors:  H L Torney; J K Dulworth; D L Steward
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

3.  Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Authors:  Adelina Stoyanova; Ivanka Nikolova; Gerhard Pürstinger; Georgi Dobrikov; Vladimir Dimitrov; Stefan Philipov; Angel S Galabov
Journal:  Antivir Chem Chemother       Date:  2016-11-04

4.  Antirhinovirus activity of purine nucleoside analogs.

Authors:  E De Clercq; R Bernaerts; D E Bergstrom; M J Robins; J A Montgomery; A Holy
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

5.  6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.

Authors:  M E González; M J Almela; M Yacout; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.

Authors:  M T Kenny; J K Dulworth; H L Torney
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  Potential use of antiviral agents in polio eradication.

Authors:  Armando M De Palma; Gerhard Pürstinger; Eva Wimmer; Amy K Patick; Koen Andries; Bart Rombaut; Erik De Clercq; Johan Neyts
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

Review 8.  Antiviral therapeutic approaches for human rhinovirus infections.

Authors:  Victor Casanova; Filipa H Sousa; Craig Stevens; Peter G Barlow
Journal:  Future Virol       Date:  2018-06-12       Impact factor: 1.831

9.  Chapter 12. Antiviral Agents.

Authors:  James L Kelley
Journal:  Annu Rep Med Chem       Date:  2008-04-10       Impact factor: 1.059

10.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.